Skip to content
ContentLora

    Tip: press / anywhere to search.

    organization

    National Institute on Drug Abuse (NIDA): what it does and funds

    Also known as NIDA, National Institute on Drug Abuse

    The National Institute on Drug Abuse (NIDA) is the part of the National Institutes of Health that funds and runs research on drug use and addiction, and calls itself the world's largest supporter of such research.[1] Congress created it on 14 May 1974; its studies include Monitoring the Future and the Adolescent Brain Cognitive Development Study.[2][3][4] The FY 2026 and FY 2027 budget requests proposed folding NIDA into a new institute; Congress kept NIH's existing structure for FY2026.[5][6]

    Editor reviewedStrict sourcingUpdated Wiki22 claims · 100% primaryDrugs, alcohol and addiction, Health and medicine
    Key facts

    NIDA is a research institute and does not offer treatment or medical advice. This page is general information, not medical advice.

    For US treatment referrals, call the SAMHSA National Helpline at 1-800-662-HELP (4357) or visit FindTreatment.gov; in a crisis, call or text 988.[7][8]

    The National Institute on Drug Abuse (NIDA) is the US federal institute for research on drug use and addiction. It is part of the National Institutes of Health and describes itself as the largest supporter of the world’s research on substance use and addiction.[1] Its stated mission is to advance science on drug use and addiction and to apply that knowledge to improve individual and public health.[9] It is a research organization and does not provide personal medical advice, treatment or counseling.[10]

    History

    An act of Congress established NIDA on 14 May 1974, and it marked its 50th anniversary in 2024.[2] It became part of NIH in 1992.[11] NIDA says its research helped shift medicine and the public from viewing addiction as deviance toward seeing it as a preventable, treatable health condition.[12]

    Milestones on NIDA’s own timeline include:

    YearMilestone
    1975Monitoring the Future survey of drug use among 12th graders and young adults launched[3]
    1999Clinical Trials Network established[13]
    2002FDA approves buprenorphine for office-based treatment of opioid use disorder[14]
    2011Population Assessment of Tobacco and Health (PATH) Study launched with FDA[3]
    2015FDA approves the first nasal naloxone spray; Adolescent Brain Cognitive Development Study launches[14][4]

    NIDA lists these among its selected achievements; the buprenorphine and nasal naloxone approvals were FDA decisions.[14]

    What it funds and runs

    NIDA’s work is organized into divisions for epidemiology, services and prevention research; extramural research; neuroscience and behavior; and therapeutics and medical consequences, alongside an Intramural Research Program and a Center for Clinical Trials Network.[15] The Clinical Trials Network brings together NIDA, treatment researchers and community-based providers to work toward new treatment options in community-level clinical practice.[13]

    The Adolescent Brain Cognitive Development Study follows more than 11,800 US children through adolescence into young adulthood, and NIDA supports the HEALthy Brain and Child Development Study, which will follow mothers and infants from pregnancy through age 10.[4][16] NIDA also funds the National Drug Early Warning System, which tracks where substances such as xylazine appear.[17]

    NIDA’s research and summaries feed into policy debates covered elsewhere on this site:

    Proposed consolidation

    The President’s FY 2026 budget proposed consolidating NIDA into a new National Institute of Behavioral Health, and the FY 2027 budget proposed consolidating it into a National Institute of Substance Use and Addiction Research (NISUAR).[5] Congress’s FY2026 appropriations kept NIH’s existing structure rather than the proposed reorganization.[6]

    NIDA’s website lists Nora D. Volkow, M.D., as having become director in May 2003.[22]

    This page will be updated if Congress acts on the FY 2027 consolidation proposal. It does not cover NIDA’s budget figures or grant terminations; see the NIH page for agency-wide funding.

    Next in the crash course

    More in Drugs & addiction

    Questions readers ask

    What does NIDA do?

    NIDA conducts and supports biomedical research on drug use and addiction. Its stated mission is to advance that science and apply it to improve individual and public health. It is a research organization and does not provide personal medical advice or treatment.[1][9][10]

    Can NIDA help me find addiction treatment?

    No. NIDA does not provide treatment, but for US treatment referrals it points people to the SAMHSA National Helpline, 1-800-662-HELP (4357), and FindTreatment.gov. In a crisis, call or text 988.[10][7][8]

    When was NIDA created?

    An act of Congress established NIDA on 14 May 1974, and it became part of the National Institutes of Health in 1992.[2][11]

    What major studies does NIDA run?

    NIDA's timeline lists Monitoring the Future (launched 1975), the PATH tobacco study with FDA (2011) and the Adolescent Brain Cognitive Development Study (2015), which follows more than 11,800 US children. It also supports the HEALthy Brain and Child Development Study.[3][4][16]

    Is NIDA being merged into another institute?

    The President's FY 2026 budget proposed consolidating NIDA into a National Institute of Behavioral Health, and the FY 2027 budget proposed a National Institute of Substance Use and Addiction Research. Congress's FY2026 appropriations kept NIH's existing structure.[5][6]

    Sources

    · 22 claims from 3 publishers

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      NIDA, part of the National Institutes of Health, describes itself as the largest supporter of the world's research on substance use and addiction. confirmedas of 2026-11-07

      • Research Topics · National Institute on Drug Abuse · Primary source · Research Topics introduction (retrieved 2026-11-07)
      • Research Topics · National Institute on Drug Abuse · Primary source · Research Topics introduction (retrieved 2026-11-07)
    2. [2]

      NIDA was established by an act of Congress on 14 May 1974 and marked its 50th anniversary in 2024. confirmedas of 2026-11-07

      • NIDA 50th Anniversary · National Institute on Drug Abuse · Primary source · 50th anniversary page (retrieved 2026-11-07)
    3. [3]

      NIDA's timeline credits it with launching the Monitoring the Future survey of drug use among 12th graders and young adults in 1975 and, with FDA, the Population Assessment of Tobacco and Health (PATH) Study in 2011. confirmedas of 2026-11-07

      • NIDA 50th Anniversary · National Institute on Drug Abuse · Primary source · Timeline of Notable Achievements (retrieved 2026-11-07)
      • NIDA 50th Anniversary · National Institute on Drug Abuse · Primary source · Timeline of Notable Achievements (retrieved 2026-11-07)
    4. [4]

      The Adolescent Brain Cognitive Development Study, launched in 2015, follows more than 11,800 US children through adolescence into young adulthood. confirmedas of 2026-11-07

      • NIDA 50th Anniversary · National Institute on Drug Abuse · Primary source · Timeline of Notable Achievements, 2015 (retrieved 2026-11-07)
    5. [5]

      The FY 2026 President's budget proposed consolidating NIDA into a National Institute of Behavioral Health, and the FY 2027 budget proposed consolidating it into a National Institute of Substance Use and Addiction Research (NISUAR). confirmedas of 2026-11-07

      • Budget Information · National Institute on Drug Abuse · Primary source · Fiscal Year 2026 Budget Information (retrieved 2026-11-07)
      • Budget Information · National Institute on Drug Abuse · Primary source · Budget Information (FY 2027) (retrieved 2026-11-07)
    6. [6]

      The Consolidated Appropriations Act, 2026, signed on 3 February 2026, gave NIH a program level of $47.493 billion, 1.0% more than in FY2025, and kept NIH's existing structure rather than the proposed reorganisation. confirmedas of 2026-05-18

    7. [7]

      The SAMHSA National Helpline, 1-800-662-HELP (4357), and FindTreatment.gov give US referrals to substance use and mental health treatment programs. confirmedas of 2026-11-07

      • Research Topics · National Institute on Drug Abuse · Primary source · In an emergency? Need treatment? (retrieved 2026-11-07)
    8. [8]

      People in the US experiencing a substance use or mental health crisis can call or text 988, or chat at 988lifeline.org, to reach the 988 Suicide & Crisis Lifeline. confirmedas of 2026-11-07

      • Research Topics · National Institute on Drug Abuse · Primary source · In an emergency? Need treatment? (retrieved 2026-11-07)
    9. [9]

      NIDA's stated mission is to advance science on drug use and addiction and apply that knowledge to improve individual and public health. confirmedas of 2026-11-07

      • About NIDA · National Institute on Drug Abuse · Primary source · About NIDA (retrieved 2026-11-07)
    10. [10]

      NIDA says it is a biomedical research organization and does not provide personal medical advice, treatment or counseling. confirmedas of 2026-11-07

      • Research Topics · National Institute on Drug Abuse · Primary source · Disclaimer (retrieved 2026-11-07)
    11. [11]

      NIDA became part of the National Institutes of Health in 1992. confirmedas of 2026-11-07

      • NIDA 50th Anniversary · National Institute on Drug Abuse · Primary source · Timeline of Notable Achievements (retrieved 2026-11-07)
    12. [12]

      NIDA says its research helped shift medicine and the public from viewing addiction as deviance toward seeing it as a preventable, treatable health condition. confirmedas of 2026-11-07

      • NIDA 50th Anniversary · National Institute on Drug Abuse · Primary source · 50th anniversary page (retrieved 2026-11-07)
    13. [13]

      NIDA established its Clinical Trials Network in 1999; the network brings together NIDA, treatment researchers and community-based service providers to work toward new treatment options in community-level clinical practice. confirmedas of 2026-11-07

      • NIDA 50th Anniversary · National Institute on Drug Abuse · Primary source · Timeline of Notable Achievements (retrieved 2026-11-07)
      • Clinical Trials Network (CTN) · National Institute on Drug Abuse · Primary source · Clinical Trials Network page (retrieved 2026-11-07)
    14. [14]

      NIDA's timeline of selected achievements lists FDA's 2002 approval of buprenorphine for office-based treatment of opioid use disorder and its 2015 approval of the first nasal naloxone spray. confirmedas of 2026-11-07

      • NIDA 50th Anniversary · National Institute on Drug Abuse · Primary source · Timeline of Notable Achievements (retrieved 2026-11-07)
      • NIDA 50th Anniversary · National Institute on Drug Abuse · Primary source · Timeline of Notable Achievements (retrieved 2026-11-07)
    15. [15]

      NIDA's extramural and intramural work is organized into divisions for epidemiology, services and prevention research; extramural research; neuroscience and behavior; and therapeutics and medical consequences, plus an Intramural Research Program and a Center for Clinical Trials Network. confirmedas of 2026-11-07

      • Organization · National Institute on Drug Abuse · Primary source · Divisions/Centers (retrieved 2026-11-07)
      • Organization · National Institute on Drug Abuse · Primary source · Divisions/Centers (retrieved 2026-11-07)
    16. [16]

      NIDA supports the HEALthy Brain and Child Development Study, which will follow mothers and their infants from pregnancy through age 10. confirmedas of 2026-11-07

      • Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Does cannabis use during pregnancy affect a developing baby? (retrieved 2026-11-07)
    17. [17]

      NIDA supports the National Drug Early Warning System (NDEWS), which tracks where substances including xylazine appear across the country. confirmedas of 2026-11-07

      • Xylazine · National Institute on Drug Abuse · Primary source · What substances has xylazine been found in? (retrieved 2026-11-07)
    18. [18]

      NIDA concurred with FDA's recommendation that marijuana be moved from Schedule I to Schedule III. confirmedas of 2026-11-07

    19. [19]

      NIDA says studies estimate 22% to 30% of people who use cannabis have cannabis use disorder, and that how often someone uses is the strongest predictor. confirmedas of 2026-11-07

      • Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Is cannabis addictive? (retrieved 2026-11-07)
      • Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Is cannabis addictive? (retrieved 2026-11-07)
    20. [20]

      NIDA says much is still unknown about the short- and long-term health and safety effects of kratom, and it supports and conducts research on kratom's potential medicinal uses. confirmedas of 2026-11-07

      • Kratom · National Institute on Drug Abuse · Primary source · What is kratom? (retrieved 2026-11-07)
      • Kratom · National Institute on Drug Abuse · Primary source · Highlights (retrieved 2026-11-07)
    21. [21]

      NIDA funds research on overdose prevention centers in the United States but does not fund their operation. confirmedas of 2026-11-07

    22. [22]

      NIDA's website lists Nora D. Volkow, M.D., as having become NIDA's director in May 2003. confirmedas of 2026-11-07

      • About NIDA · National Institute on Drug Abuse · Primary source · Director's Page (retrieved 2026-11-07)
    Revision history (1)
    1. Page created.

    Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Feb 7, 2027.

    Cite this page

    "National Institute on Drug Abuse (NIDA): what it does and funds." ContentLora, updated Nov 7, 2026. https://contentlora.com/wiki/national-institute-on-drug-abuse

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.